Dealmaking in US healthcare remained stable in 2025 relative to the sector’s M&A activity in 2023 and 2024. According to McKinsey’s analysis, dealmakers continued to diversify, with a focus on obtaining new capabilities to improve their portfolios. In previous years, by contrast, organizations sought to diversify largely to access new value pools. M&A activity and motivations varied across different players within the healthcare ecosystem. More than 75 percent of deals by providers were focused on consolidation plays, with more than 15 percent of these deals focused on acquiring healthcare-services and -technology (HST) capabilities to maximize the worth of their existing assets.
Read the full article: US Healthcare: Companies Continue to Create Value through Diversification //
Source: https://www.mckinsey.com/capabilities/m-and-a/our-insights/us-healthcare-companies-continue-to-create-value-through-diversification